1. Home
  2. AVNW vs TRDA Comparison

AVNW vs TRDA Comparison

Compare AVNW & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

HOLD

Current Price

$21.39

Market Cap

278.2M

Sector

Technology

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$7.07

Market Cap

268.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNW
TRDA
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
278.2M
268.6M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
AVNW
TRDA
Price
$21.39
$7.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$34.50
$21.00
AVG Volume (30 Days)
124.7K
318.9K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$243,858,000.00
$25,421,000.00
Revenue This Year
$5.59
$39.97
Revenue Next Year
$7.03
$50.80
P/E Ratio
$72.93
N/A
Revenue Growth
0.56
N/A
52 Week Low
$13.92
$5.02
52 Week High
$27.02
$16.45

Technical Indicators

Market Signals
Indicator
AVNW
TRDA
Relative Strength Index (RSI) 52.24 51.42
Support Level $20.60 $5.71
Resistance Level $22.59 $7.95
Average True Range (ATR) 0.77 0.39
MACD -0.07 0.02
Stochastic Oscillator 43.37 51.92

Price Performance

Historical Comparison
AVNW
TRDA

About AVNW Aviat Networks Inc.

Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: